Marking Blood Cancer Awareness Month, CLL Advocates NZ highlights the value of collaboration, knowledge sharing, and patient support both in New Zealand and internationally. The update covers the launch of a new patient guide, the upcoming inaugural CLL seminar, opportunities to engage with global CLL networks, and the importance of advocating for better access to treatments.

CLL Advocates NZ highlights a range of research initiatives aimed at improving outcomes for people living with CLL, including clinical trial opportunities, studies into secondary cancers, and participation in New Zealand health research. The update also encourages patient involvement in research and provides an early reminder about the upcoming national CLL education forum.

CLL Advocates NZ highlights valuable international patient resources, including HealthUnlocked and Patient Power, and shares emerging research on COVID-19 outcomes for people living with CLL. The update also explores developments in CAR T-cell therapy and invites patients and families to the organisation's first national CLL education event.

In its inaugural newsletter, CLL Advocates NZ shares priorities for supporting the CLL community through education, advocacy, and connection. The update includes guidance on managing CLL during the COVID-19 pandemic, introduces new patient information resources, and announces plans for a national CLL seminar featuring leading New Zealand specialists.